Universitätsfrauen- und Poliklinik am Klinikum Suedstadt
Rostock, Germany
General hospital in Rostock, Mecklenburg-Vorpommern
Südring 81, 18059 Rostock
About Universitätsfrauen- und Poliklinik am Klinikum Suedstadt
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Universitätsfrauen- und Poliklinik am Klinikum Suedstadt
During the past decade, Universitätsfrauen- und Poliklinik am Klinikum Suedstadt conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 5 clinical trials were completed, i.e. on
average, 125% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Herceptin (Trastuzumab) in Treating Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Primary Breast Cancer
2001-11-01
2015-06-01
Completed
5,099
Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer
2002-04-01
Terminated
351
AURELIA: A Study of Avastin (Bevacizumab) Added to Chemotherapy in Patients With Platinum-resistant Ovarian Cancer
2009-10-29
2014-07-09
Completed
361
A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer
2011-11-08
2028-11-30
Active, not recruiting
4,804
Pertuzumab in Platinum-Resistant Low Human Epidermal Growth Factor Receptor 3 (HER3) Messenger Ribonucleic Acid (mRNA) Epithelial Ovarian Cancer (PENELOPE)
2012-10-22
2016-04-28
Completed
208
A Study of Trastuzumab Emtansine Versus Trastuzumab as Adjuvant Therapy in Patients With HER2-Positive Breast Cancer Who Have Residual Tumor in the Breast or Axillary Lymph Nodes Following Preoperative Therapy (KATHERINE)
2013-04-03
2025-04-03
Active, not recruiting
1,487
Comparison of Axillary Sentinel Lymph Node Biopsy Versus no Axillary Surgery
2015-09-01
2024-12-01
Active, not recruiting
5,505
A Study of Ipatasertib in Combination With Paclitaxel as a Treatment for Participants With PIK3CA/AKT1/PTEN-Altered, Locally Advanced or Metastatic, Triple-Negative Breast Cancer or Hormone Receptor-Positive, HER2-Negative Breast Cancer
2018-01-06
2023-01-04
Completed
580
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Universitätsfrauen- und Poliklinik am Klinikum Suedstadt"
#1 collaborator was "Breast International Group" with 2 trials as a collaborator, "German Breast Group" with 2 trials as a collaborator, "ETOP IBCSG Partners Foundation" with 1 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 8 trials.
Clinical Trials Conditions at Universitätsfrauen- und Poliklinik am Klinikum Suedstadt
According to Clinical.Site data, the most researched conditions in "Universitätsfrauen- und Poliklinik am Klinikum Suedstadt" are
"Breast Cancer" (6 trials), "Ovarian Cancer" (2 trials), "Chronic Myeloproliferative Disorders" (1 trials), "Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer" (1 trials) and "Fever, Sweats, and Hot Flashes" (1 trials). Many other conditions were trialed in "Universitätsfrauen- und Poliklinik am Klinikum Suedstadt" in a lesser frequency.
Clinical Trials Intervention Types at Universitätsfrauen- und Poliklinik am Klinikum Suedstadt
Most popular intervention types in "Universitätsfrauen- und Poliklinik am Klinikum Suedstadt" are "Drug" (8 trials), "Procedure" (2 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Paclitaxel" (2 trials), "Pertuzumab" (2 trials), "5-Fluorouracil" (1 trials) and "Bevacizumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Universitätsfrauen- und Poliklinik am Klinikum Suedstadt
The vast majority of trials in "Universitätsfrauen- und Poliklinik am Klinikum Suedstadt" are
6 trials for "All" genders and 4 trials for "Female" genders.
Clinical Trials Status at Universitätsfrauen- und Poliklinik am Klinikum Suedstadt
Currently, there are NaN active trials in "Universitätsfrauen- und Poliklinik am Klinikum Suedstadt".
undefined are not yet recruiting,
undefined are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Universitätsfrauen- und Poliklinik am Klinikum Suedstadt,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Universitätsfrauen- und Poliklinik am Klinikum Suedstadt, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".